ambroxol has been researched along with Lysosomal Enzyme Disorders in 2 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyd, RE | 1 |
| Lee, G | 1 |
| Rybczynski, P | 1 |
| Benjamin, ER | 1 |
| Khanna, R | 1 |
| Wustman, BA | 1 |
| Valenzano, KJ | 1 |
| Jiang, W | 1 |
| Yi, M | 1 |
| Maegawa, GHB | 1 |
| Zhang, H | 1 |
1 review available for ambroxol and Lysosomal Enzyme Disorders
| Article | Year |
|---|---|
Pharmacological chaperones as therapeutics for lysosomal storage diseases.
Topics: Cell Line; Glycolipids; Humans; Lysosomal Storage Diseases; Molecular Chaperones; Structure-Activity | 2013 |
1 other study available for ambroxol and Lysosomal Enzyme Disorders
| Article | Year |
|---|---|
Ambroxol improves skeletal and hematological manifestations on a child with Gaucher disease.
Topics: Ambroxol; Child; Enzyme Replacement Therapy; Gaucher Disease; Glucosylceramidase; Humans; Lysosomal | 2020 |